Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Lib Therapeutics LLC
Sponsor

Lib Therapeutics LLC

United States 5375 Medpace Way, 45227-1543, United States

About the sponsor

LIB Therapeutics Inc. focuses on cholesterol-lowering research for heterozygous familial hypercholesterolemia and homozygous familial hypercholesterolemia, with studies addressing persistent LDL cholesterol elevation in patients receiving background lipid-lowering therapy.

  • HeFH
  • HoFH
  • LDL-C reduction

The sponsor’s clinical work in this area includes both adult and pediatric populations affected by inherited lipid disorders.

About Specializations

Lib Therapeutics LLC runs clinical trials in conditions such as Type IIa hyperlipidaemia, Cardiovascular disorder, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Type IIa hyperlipidaemia

Recruiting
Investigational
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Lerodalcibep
  • Sponsor:Lib Therapeutics LLC

Cardiovascular disorder+1

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lerodalcibep
  • Sponsor:Lib Therapeutics LLC

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.